Patents by Inventor Devender Singh-Sandhu

Devender Singh-Sandhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
    Patent number: 8946174
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: February 3, 2015
    Assignee: Sanofi Pasteur Limited
    Inventors: Neil Berinstein, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Scott Gallichan, Devender Singh-Sandhu, Raymond P. Oomen, Shi-Xian Cao
  • Monoclonal antibodies and uses thereof
    Patent number: 8361706
    Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.
    Type: Grant
    Filed: July 14, 2010
    Date of Patent: January 29, 2013
    Assignee: Sanofi Pasteur Limited
    Inventors: Neil Berinstein, Devender Singh-Sandhu, Corey Lovitt, Artur Pedyczak, Laszlo Radvanyi, Scott Gallichan
  • Tumor Antigens for the Prevention and/or Treatment of Cancer
    Publication number: 20130011422
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: May 31, 2012
    Publication date: January 10, 2013
    Inventors: Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Laszlo Radvanyi, Devender Singh-Sandhu
  • Tumor antigens for prevention and/or treatment of cancer
    Patent number: 8207314
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Grant
    Filed: April 15, 2004
    Date of Patent: June 26, 2012
    Assignee: Sanofi Pasteur Limited
    Inventors: Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Laszlo Radvanyi, Devender Singh-Sandhu
  • Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer
    Publication number: 20110311543
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: August 23, 2011
    Publication date: December 22, 2011
    Inventors: Neil Berinstein, Scott Gallichan, Corey Lovitt, Parrington Mark, Artur Pedyczak, Laszio Radvanyi, Devender Singh-Sandhu
  • Tumor antigens Bfa5 for prevention and/or treatment of cancer
    Patent number: 8021664
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Grant
    Filed: April 15, 2004
    Date of Patent: September 20, 2011
    Assignee: Sanofi Pasteur Limited
    Inventors: Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Devender Singh-Sandhu
  • TUMOR ANTIGENS BFA4 AND BCY1 FOR PREVENTION AND / OR TREATMENT OF CANCER
    Publication number: 20110117640
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: September 23, 2010
    Publication date: May 19, 2011
    Inventors: Neil Berinstein, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Scott Gallichan, Devender Singh-Sandhu, Raymond P. Oomen, Shi-Xian Cao
  • Monoclonal Antibodies and Uses Thereof
    Publication number: 20110045502
    Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.
    Type: Application
    Filed: July 14, 2010
    Publication date: February 24, 2011
    Applicant: Sanofi Pasteur, Ltd.
    Inventors: Neil Berinstein, Devender Singh-Sandhu, Corey Lovitt, Artur Pedyczak, Laszlo Radvanyi
  • Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
    Patent number: 7851213
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Grant
    Filed: July 1, 2003
    Date of Patent: December 14, 2010
    Assignee: Sanofi Pasteur Limited
    Inventors: Neil Berinstein, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Scott Gallichan, Devender Singh-Sandhu, Raymond P. Oomen, Shi-Xian Cao
  • TUMOR ANTIGEN BFY3 FOR PREVENTION AND/OR TREATMENT OF CANCER
    Publication number: 20100278848
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: April 15, 2004
    Publication date: November 4, 2010
    Applicant: AVENTIS PASTEUR, INC.
    Inventors: Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Laszlo Radvanyi, Devender Singh-Sandhu
  • Monoclonal antibodies and uses thereof
    Patent number: 7790857
    Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: September 7, 2010
    Assignee: Sanofi Pasteur Limited
    Inventors: Neil Berinstein, Devender Singh-Sandhu, Corey Lovitt, Artur Pedyczak, Laszlo Radvanyi
  • Monoclonal antibodies and uses thereof
    Publication number: 20080280309
    Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.
    Type: Application
    Filed: February 8, 2007
    Publication date: November 13, 2008
    Applicant: Sanofi Pasteur, Ltd.
    Inventors: Neil Berinstein, Devender Singh-Sandhu, Corey Lovitt, Artur Pedyczak, Laszlo Radavanyi
  • Tumor Antigens Bfa5 For Prevention And/Or Treatment Of Cancer
    Publication number: 20080138365
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: April 15, 2004
    Publication date: June 12, 2008
    Inventors: Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Devender Singh-Sandhu
  • Tumor antigen BFA5 for prevention and / or treatment of cancer
    Publication number: 20050112099
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: April 15, 2004
    Publication date: May 26, 2005
    Applicant: Aventis Pasteur, Ltd.
    Inventors: Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Devender Singh-Sandhu
  • Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
    Publication number: 20040197912
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: July 1, 2003
    Publication date: October 7, 2004
    Applicant: Aventis Pasteur, Ltd.
    Inventors: Neil Berinstein, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Scott Gallichan, Devender Singh-Sandhu, Raymond P. Oomen, Shi-Xian Cao